+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Advances in Clinical Chemistry. Volume 112

  • Book
  • January 2023
  • Elsevier Science and Technology
  • ID: 5658512
Advances in Clinical Chemistry, Volume 112 highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Heterogeneity in Major Depressive Disorder: The need for Biomarker-based and Personalized Treatments, Advances in exosome analysis, Translational Proteomics and Phosphoproteomics: Tissue to Extracellular Vesicles, Immune Checkpoint Therapy, Tumor Immunology, and Biomarkers in Non-Small-Cell Lung Cancer, Advances in Congestive Heart Failure Biomarkers, Fluid biomarkers in Alzheimer's disease, and more.

Table of Contents

1. Heterogeneity in Major Depressive Disorder: The need for Biomarker-based  Personalized Treatments
Shayam Suseelan and Graziano Pinna
2. Advances in exosome analysis
Arnau Pallares-Rusiñol, Mireia Bernuz, Silio Lima Moura Carolina Fernández-Senac, Rosanna Rossi, Mercè Martí, and Isabel Pividori
3. Translational Proteomics and Phosphoproteomics: Tissue to Extracellular Vesicles
Xiaofeng Wu, Anton B. Iliuk and W. Andy Tao
4. Immune Checkpoint Therapy, Tumor Immunology, and Biomarkers in Non-Small-Cell Lung Cancer
Koji Kurose, Kanako Sakaeda, Minoru Fukuda, Yumiko Sakai, Hiroyuki Yamaguchi, Shinnosuke Takemoto, Katsuhiko Shimizu, Takeshi Masuda, Katsumi Nakatomi, Shigeo Kawase, Ryo Tanaka, Takayuki Suetsugu, Keiko Mizuno, Takehiro Hasegawa, Yusuke Atarashi, Yasuhiro Irino, Toshiyuki Sato, Hiromasa Inoue, Noboru Hattori, Eiichiro Kanda, Masao Nakata, Hiroshi Mukae, Toru Oga, and Mikio Oka
5. Advances in Congestive Heart Failure Biomarkers
Iyyapu Krishna Mohan, K. S. S. Sai Baba, Rohit Iyyapu, Sunitha Thirumalasetti and O. Sai Satish
6. Fluid biomarkers in Alzheimer's disease
Joel Simrén, Anders Elmgren, Kaj Blennow and Henrik Zetterberg

Authors

Gregory S. Makowski Vice President and Chief Scientific Officer for Clinical Laboratory Partners in Newington CT, USA.. Dr Gregory S Makowski is a board certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in his joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President and Chief Scientific Officer for Clinical Laboratory Partners in Newington CT, USA.